Frederick S Ey, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 15700 Sw Greystone Court, Beaverton, OR 97006 Phone: 503-203-1000 Fax: 503-203-1010 |
Kevin W.h. Yee, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 15700 Sw Greystone Court, Beaverton, OR 97006 Phone: 503-203-1000 Fax: 503-203-1010 |
Gary W Takahashi, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 15700 Sw Greystone Court, Beaverton, OR 97006 Phone: 503-203-1000 Fax: 503-203-1010 |
News Archive
CeNeRx BioPharma, Inc. has announced the initiation of human clinical trials of Tyrima, CeNeRx's new drug candidate with a triple mechanism of action for the treatment of depression and anxiety.
Three months ago, the nation watched as COVID-19 patients overwhelmed New York City's intensive care units, forcing some of its hospitals to convert cafeterias into wards and pitch tents in parking lots.
Rani Therapeutics announced today that it has entered into a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, to evaluate Rani's novel oral drug delivery platform. The companies have agreed to conduct feasibility studies over the next two years, in which Rani will test select biologic molecules in the area of metabolic disease to evaluate the oral delivery of these molecules.
Alnylam Pharmaceuticals, Inc.,a leading RNAi therapeutics company, announced today that it will make a total of 16 oral presentations at the American Chemical Society (ACS) Fall 2010 240th National Meeting & Exposition being held in Boston, Mass. from August 22-26, 2010.
› Verified 2 days ago